Welcome to our dedicated page for Stepan SEC filings (Ticker: SCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Stepan Company (NYSE: SCL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret the details. As a public issuer in the specialty and intermediate chemicals space, Stepan files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that describe its surfactants, polymers and specialty products businesses, financial results and governance matters.
In Stepan’s 10-K and 10-Q filings, readers can review segment information for surfactants, polymers and specialty products, along with discussions of sales volumes, selling prices, raw material cost pass-through, product mix and operating income. These reports also cover topics such as the company’s global manufacturing footprint in North and South America, Europe and Asia, and its role as a leading merchant producer of surfactants and supplier of polyurethane polyols for thermal insulation and CASE markets.
Form 8-K current reports provide updates on specific events, including quarterly earnings releases, dividend declarations, executive appointments or departures, board changes and adoption of plans such as the Key Executive Severance Benefit Plan. These filings give timely insight into Stepan’s capital allocation, leadership structure and key corporate actions.
Stock Titan enhances access to Stepan’s filings with AI-generated summaries that highlight the most important points in lengthy documents, helping users quickly understand complex financial and legal language. Real-time updates from EDGAR ensure that new Stepan filings appear promptly, while dedicated views for insider transaction reports (Form 4), proxy statements (Schedule 14A) and other forms allow deeper analysis of executive compensation, ownership changes and governance practices. This page serves as a focused resource for anyone researching SCL through its official SEC record.
STEPAN CO reported new equity awards granted to Vice President and Chief Financial Officer Ruben Dario Velasquez. On February 27, 2026, he acquired 35.601 shares of common stock at $52.51 per share as an award. On March 2, 2026, he received grants of 5,993 restricted stock units, 2,996 performance shares, and 8,586 stock appreciation rights, all recorded at a price of $0. Each restricted stock unit and performance share represents a contingent right to receive one share of common stock, with the restricted stock units vesting ratably over three years and the performance shares vesting based on performance goals for a period ending December 31, 2028.
Stepan Co President & CEO Luis Rojo reported equity awards that increase his stake in the company. On March 2, 2026, he received 19,976 Restricted Stock Units, 39,952 performance shares, and a Stock Appreciation Right covering 57,241 shares, all at a stated price of $0.00 per unit.
Each RSU and performance share represents a contingent right to receive one share of Stepan common stock, with RSUs vesting in equal installments over three years and performance shares vesting after certification of performance for the period ending December 31, 2028. On February 27, 2026, he also acquired 56.765 shares of common stock at $52.51 per share, bringing his directly held common stock to 15,697.666 shares, plus 511.83 shares held indirectly through an ESOP II trust.
Stepan Company files its annual report describing a global specialty and intermediate chemicals business organized into Surfactants, Polymers and Specialty Products. It sells mainly to manufacturers rather than directly to consumers, serving cleaning, personal care, construction, agriculture, oilfield and food/pharma markets.
The company highlights environmental and regulatory compliance, spending $9.8 million on related capital projects and $44.9 million on recurring environmental operating costs in 2025. It launched Project Catalyst in February 2026, targeting about $100 million in pre-tax savings over two years through operational and efficiency initiatives.
Management discusses key risks, including hazardous chemical operations, raw material and energy volatility, transportation disruptions, geopolitical tensions, evolving chemical and product regulations, cybersecurity threats and legal liabilities. Stepan also notes significant indebtedness, with long-term notes and a revolving credit facility, and emphasizes strong safety culture, human capital development and a formal enterprise risk management and cybersecurity governance framework.
Stepan Company announced Project Catalyst, a comprehensive operational and efficiency plan targeting approximately $100 million in pre-tax savings over the next two years. To achieve this, the company will close its Fieldsboro, New Jersey site and decommission select assets at its Elwood (Millsdale), Illinois and Stalybridge, United Kingdom facilities by mid-2026, consolidating production into its existing network.
Stepan expects restructuring charges of $70–$80 million in 2026, with about $52–$62 million recognized in the first quarter of 2026. Over the life of the project, cash impacts are projected at $29–$44 million and non-cash impacts at $58–$62 million, primarily related to asset write-downs, decommissioning costs and related expenses.
Stepan Company reported solid full-year 2025 growth with signs of near-term pressure. Net sales rose to
Adjusted net income fell
The company launched Project Catalyst, targeting about
STEPAN CO President & CEO Luis Rojo reported equity award activity involving restricted stock units and common shares. On the reported date, 683 restricted stock units were exercised and settled into 683 shares of common stock at $66.3900 per share. To cover tax obligations, 237 common shares were disposed of through a tax-withholding transaction, leaving 15,640.901 common shares held directly after these transactions. An additional 511.8300 common shares are held indirectly through the Esop II Trust. The filing also amends a prior report to correct the dates for “Date Exercisable” and “Expiration Date” on the related award.
STEPAN CO executive Richard Finn, Vice President and General Manager of Polymers, reported equity award activity in company stock. On February 17, 2026, 341 restricted stock units were exercised and settled into 341 shares of common stock at $66.39 per share, consistent with the award terms.
To cover taxes on the RSU vesting, 118 shares of common stock were withheld, also at $66.39 per share. After these transactions, Finn directly held 241,339.15 shares of common stock. He also reported indirect holdings, including 43,439 shares held by a daughter, 5,174 by a spouse, 95,416 by a trust, and 1,238.22 by an ESOP II trust.
Stepan Company executive Sean Thomas Moriarty reported equity award activity involving restricted stock units and common stock. On February 17, 2026, 455 restricted stock units were exercised into 455 shares of Stepan common stock at a stated price of $66.39 per share, consistent with an exercise or conversion of derivative securities. To cover tax obligations on the RSU vesting, 158 common shares were disposed of through share withholding, rather than an open-market sale. After these transactions, Moriarty directly holds 14,145.4635 shares of Stepan common stock and indirectly holds 4,478.3510 shares through the ESOP II Trust.
Stepan Company’s President and CEO Luis Rojo reported equity award activity involving restricted stock units and common shares. On February 17, 2026, 683 restricted stock units were settled into 683 shares of common stock, consistent with the award terms where each unit equals one share.
To cover tax obligations related to this settlement, 237 restricted stock units were disposed of at a price of $66.39 per share. Following these transactions, Rojo directly owns 795 restricted stock units and 15,877.901 shares of common stock, plus an additional 511.83 shares held indirectly through the ESOP II Trust.
STEPAN CO director Quinn Stepan Jr. reported an indirect transaction involving share units tied to a deferred compensation arrangement rather than open-market trading. On February 9, 2026, 7,517.35 Share Units, each economically equivalent to one share of common stock, were involved in an exercise or conversion of a derivative security under the Management Incentive Plan, a nonqualified deferred compensation plan. According to the footnotes, these share units were settled in cash, and the holdings are reported as indirect, including amounts held through a father's deferred MIP and an estate for which he serves as executor. After the transaction, indirect holdings related to this arrangement totaled 35,649.518 Share Units.